The pharma group has just announced that it will build four new manufacturing facilities in the US – at a cost of around $27 billion – raising its total planned spending on US capital projects to more than $50 billion, which it claims is the largest pharma manufacturing investment in US history.
The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry to reshore drug production.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback